Clinical Trials Logo

Clinical Trial Summary

Towards the goal of reducing melioidosis, this study will help clinicians in Sarawak to diagnose and understand the causes and risk factors for melioidosis. The data will help the clinicians to provide faster test results and better clinical care. The investigator's laboratory efforts will supplement available diagnostics by adding a new, easier-to-use test involving lateral flow immunoassay to rapidly detect Burkholderia pseudomallei, a bacterium causing melioidosis. The study aims to study up to 400 patients with melioidosis-like symptoms who are admitted to Kapit Hospital, Sarawak, Malaysia. No participants will be enrolled from other sites. The study will also examine the demographic, behavioral and occupational risk factors associated with hospital admissions to understand any existing associations between these variables and melioidosis prevalence.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03528265
Study type Observational
Source Duke University
Contact
Status Completed
Phase
Start date June 21, 2018
Completion date January 8, 2019

See also
  Status Clinical Trial Phase
Completed NCT04299412 - Diagnostic Accuracy of the DPP II Assay
Recruiting NCT06089668 - An Observational Study to Evaluate Clinical Characteristics of Adult Patients With Suspected or Confirmed Melioidosis
Completed NCT05105035 - Oral ARV-1801 Given in Combination With Intravenous Ceftazidime or Meropenem for Treatment of Melioidosis in Hospitalized Patients Phase 2
Completed NCT01766830 - Rapid Diagnostic Tests and Clinical/Laboratory Predictors of Tropical Diseases In Patients With Persistent Fever in Cambodia, Nepal, Democratic Republic of the Congo and Sudan (NIDIAG-Fever) N/A
Recruiting NCT03048513 - Clinical Presentation of Melioidosis in Head and Neck Region N/A
Completed NCT02668406 - Study to Obtain Blood and Voided Urine Samples to Improve the Diagnosis of Melioidosis
Recruiting NCT00579956 - A Randomized Double Blinded Comparison of Ceftazidime and Meropenem in Severe Melioidosis N/A
Completed NCT01420341 - Co-trimoxazole as Maintenance Therapy for Melioidosis Phase 4
Completed NCT02089152 - A Single-blind Stepped Wedge Cluster Randomized Controlled Behaviour Change Trial to Determine Effectiveness of Prevention Programme of Melioidosis in Diabetics in Ubon Ratchathani, Northeast Thailand N/A